¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acute phase reactive protein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • inspiratory phase time
    µé¼û½Ã°£, Èí±â½Ã°£
  • internal phase
    ºÐ»ê±â
  • latent phase
    1. ÀáÀç±â 2. Àẹ±â
  • leptotene phase
    °¡´Â¼¶À¯±â, ¼¼»ç±â
  • logarithmic phase
    ´ë¼öÁõ½Ä±â
  • lactiferous phase
    ¼öÀ¯±â
  • luteal phase
    Ȳ(»ö)ü±â
  • luteal phase defect
    Ȳ(»ö)ü±â°á¼Õ
  • luteal phase endometrial biopsy
    Ȳ(»ö)ü±âÀڱ󻸷»ý°Ë
  • lysogenic phase
    ¿ë¿ø±â
  • mitosis phase
    À¯»çºÐ¿­±â
  • modulation phase
    º¯Á¶À§»ó
  • manic phase
    Á¶Áõ±â, µé¶ä±â
  • menstrual phase
    ¿ù°æ±â
  • negative phase
    1. À½¼º»ó 2. Ç×ü°¨¼Ò±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • luteal phase
    Ȳü±â
  • lysogenic phase
    ¿ë¿ø±â
  • manic phase
    Á¶Áõ±â, µé¶ä±â
  • menstrual phase
    ¿ù°æ±â
  • mitosis phase
    À¯»çºÐ¿­±â
  • modulation phase
    º¯Á¶À§»ó
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • negative phase
    À½¼º±â, À½¼º»ó
  • orgasmic phase
    ±ØÄ¡±â
  • ovogenetic phase
    ³­Àڹ߻ý±â
  • phase
    »ó, ±â, À§»ó
  • pachytene phase
    ±½Àº¼¶À¯±â
  • phase ratio
    »óºñ
  • phase reversal
    À§»ó¹ÝÀü
  • phase rule
    »óÀǹýÄ¢, »ó±ÔÄ¢
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • phase difference
    À§»óÂ÷
  • phase difference haploscope
    À§»óÂ÷ÇÏÇ÷νºÄÚ¿ìÇÁ
  • phase display
    À§»ó Ç¥½Ã
  • phase encode direction
    À§»ó ºÎȣȭ ¹æÇâ
  • phase encoding
    À§»ó ºÎȣȭ
  • phase encoding gradient
    À§»ó ºÎȣȭ °æ»çµµ
  • phase encoding gradient
    À§»ó ºÎȣȭ °æ»çÀå
  • phase encoding step
    À§»ó ºÎÈ£ ´Ü°è
  • phase evolution of fat suppression
    À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
  • phase frequency swap
    À§»ó Á֯ļö ±³È¯
  • phase image
    À§»ó ¿µ»ó
  • phase mismapping
    À§»ó ¿ÀÁöµµÀÛ¼º
  • phase of cornification
    °¢Áú±â
  • phase of decline
    °¨Åð±â, °¨¼Ò±â
  • phase of desquamation
    ¹Ú¸®±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • protein calorie malnutrition
    ´Ü¹é¿­·®¿µ¾ç ½ÇÁ¶.
  • protein calorie malnutrition
    ´Ü¹é¿­·®¿µ¾ç ½ÇÁ¶(Ó±ÛÜæðÕáç½å× ã÷ðà)
  • protein decomposition
    ´Ü¹éºÐÇØ(Ó±ÛÜÝÂú°).
  • protein digest
    ´Ü¹é¼ÒÈ­¹°(Ó±ÛÜá¼ûùÚª).
  • protein error
    ´Ü¹é¿ÀÂ÷(Ó±ÛÜè¦ó¬).
  • protein extract
    ´Ü¹éÁúÃßÃâ¹°.
  • protein granule
    ´Ü¹éÁú°ú¸³
  • protein index
    ´Ü¹éÁö¼ö(Ó±ÛÜò¦â¦)
  • protein kinase
    ´Ü¹éÁú Ä«À̳×ÀÌÁî
  • protein kinase c
    ´Ü¹éÄ«À̳×À̽º(´Ü¹éŰ³ªÁ¦)C(Ó±ÛÜ¡­)
  • protein losing enteropathy
    ´Ü¹é»ó½Ç¼º À庴Áõ(Ó±ÛÜßÃã÷àõíóÜ»ñø).
  • protein losing enteropathy
    ´Ü¹é»ó½Ç¼º À庴Áõ(Ó±ÛÜßÃã÷àõ íóÜ»ñø)
  • protein losing gastroenteropathy
    ´Ü¹é»ó½Ç¼º À§ÀåÁõ(¡­êÖ ñø).
  • protein losing gastroenteropathy
    ´Ü¹é»ó½Ç¼º À§ÀåÁõ(Ó±ÛÜßÃã÷àõ êÖíóñø)
  • protein malnutrition
    ´Ü¹éÁú¿µ¾çÀå¾Ö(Ó±ÛÜòõç½å×î¡äô).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • moderator protein
    Á¶Á¤ÀڴܹéÁú(ðàïÚí­Ó±ÛÜòõ)
  • modulator protein
    Á¤Á¶´Ü¹éÁú(ïÚðàÓ±ÛÜòõ)
  • Mo-Fe protein
    Mo-Fe ´Ü¹éÁú(Ó±ÛÜòõ)
  • molybdoiron protein
    ¸ô¸®ºêµµÃ¶(ôÑ) ´Ü¹éÁú(Ó±ÛÜòõ)
  • M-protein
    M ´Ü¹éÁú(Ó±ÛÜòõ)
  • multifunctional protein
    ´Ù±â´É´Ü¹éÁú(ÒýÐüÒöÓ±ÛÜòõ)
  • multiheaded protein
    ´ÙµÎ´Ü¹éÁú(ÒýÔéÓ±ÛÜòõ)
  • mutant protein
    º¯À̴ܹéÁú(ܨì¶Ó±ÛÜòõ)
  • myelin basic protein
    ¼öÃÊ¿°±â¼º(âËÃÊç¤Ðñàõ) ´Ü¹éÁú(Ó±ÛÜòõ)
  • myelin protein A1
    ¼öÃʴܹéÁú(âËÃÊÓ±ÛÜòõ) A1
  • myeloma protein
    °ñ¼öÁ¾´Ü¹éÁú(ÍéâÐðþÓ±ÛÜòõ)
  • nonheme-iron protein
    ºñ(Þª)Èû-ö(ôÑ) ´Ü¹éÁú(Ó±ÛÜòõ)
  • omega protein
    ¿À¸Þ°¡ ´Ü¹éÁú(Ó±ÛÜòõ)
  • peripheral protein
    ÁÖº¯´Ü¹éÁú(ñ²Ü«Ó±ÛÜòõ)
  • polycephalic protein
    º¹ÇÕ±â´É ´Ü¹éÁú(ÜÜùêѦÒöÓ±ÛÜòõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
CREG Cross REactive Group (of HLA Antigens)
ReA Reactive Arthritis
ARC accelerating rate calorimetry; acquired immunodeficiency syndrome-related complex; active renin conc...
BRA bilateral renal agenesis; bone-resorbing activity; brain-reactive antibody
BRM biological response modifier; biuret reactive material
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
DSPS Delayed Sleep Phase Syndrome
DNAPL dense non-aqueous phase liquid
FPIR First-phase insulin response
HS-SPME Headspace solid phase microextraction
ISRP Internal surface reversed-phase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute glomerulonephritis
    ±Þ¼º »ç±¸Ã¼ ½Å¿°
    ÇüÅÂÇÐÀûÀ¸·Î´Â ±Þ¼º ¹Ì¸¸¼º Áõ½Ä¼º »ç±¸Ã¼½Å¿°À» ÀÏÀ¸Å°°í ÀÓ»óÀûÀ¸·Î´Â Ç÷´¢, °íÁú¼ÒÇ÷Áõ, ÇÌ´¢, °íÇ÷¾Ð µîÀÇ ±Þ¼º ½Å¿° ÁõÈıºÀ» ÁÖ¼Ò·Î ÇÏ´Â ½Å¿°À¸·Î ´Ü¹é´¢ ¹× ºÎÁ¾ µîµµ µ¿¹ÝµÉ ¼ö ÀÖÀ¸³ª ½ÅÁõÈıºº¸´Ù Á¤µµ°¡ ½ÉÇÏÁö ¾ÊÀº °æ¿ì°¡ ´ëºÎºÐÀÌ´Ù.
  • acute gouty attack
    ±Þ¼º Åëdz ¹ßº´
  • acute granulomatous uveitis
    ±Þ¼º À°¾ÆÁ¾¼º Æ÷µµ¸·¿°
  • acute heart failure
    ±Þ¼º ½ÉºÎÀü
    ±Þ¼º ¼øÈ¯ ºÎÀüÀÇ ÇϳªÀÌ°í ¿øÀÎÀÌ ½ÉÀå¿¡ ÀÖÀ» ¶§¸¦ ¸»ÇÑ´Ù. ±Þ¼º Á½ɺÎÀüÀº °íÇ÷¾Ð, ´ëµ¿¸ÆÆÇ ¹× ½Â¸ðÆÇ¸·Áõ, ½É±Ù¿°, Ư¹ß¼º ½É±ÙÁõ µî¿¡ À־ Á½ɽǿ¡ °©Àڱ⠻ý±ä ¼öÃà ºÎÀüÀ¸·Î ÀÎÇØ¼­ »ý±â´Â °ÍÀ̰í, Æó ¿ïÇ÷À» °¡Á®¿Í ¹ßÀÛ¼º È£Èí°ï¶õÀÌ »ý±ä´Ù. ±Þ¼º ¿ì½ÉºÎÀüÀº ±Þ¼º Æó»öÀü, ½É±Ù¿° µî¿¡ ÀÇÇØ ¿ì½ÉÀÇ ±Þ¼º ¼öÃà ºÎÀüÀÌ »ý°åÀ» ¶§¿¡ ÀÏÀ¸Å°°í ¿ì½ÉÀ¸·ÎÀÇ È¯·ù °¨¼Ò·Î ÀÎÇØ¼­ Ç÷¾ÐÀúÇÏ, ¼îÅ©°¡ »ý±ä´Ù. È£Èí°ï¶õ, ºóÈ£ÈíÀ» ³ªÅ¸³»±âµµ ÇÑ´Ù.
  • acute hemolytic transfusion reaction
    ±Þ¼º ¿ëÇ÷¼º ¼öÇ÷ ¹ÝÀÀ
  • acute hemorrhagic cystitis
    ±Þ¼º ÃâÇ÷¼º ¹æ±¤¿°
    ±Þ¼ºÀ¸·Î ¹ß»ýÇÏ´Â Ç÷´¢¸¦ Ư¡À¸·Î ÇÏ°í ¹è´¢Åë, ºó´¢, ¹ß¿­ÀÌ ÁÖ¿ä Áõ»óÀÎ ¹æ±¤¿°ÀÌ´Ù. ƯÈ÷ ¿¬·É, ¼º Â÷À̰¡ ¾ø°í ¼Ò¾Æ±â¿¡ ºñ±³Àû ¸¹Àº ÁúȯÀÌ´Ù. ¾Æµ¥³ë ¹ÙÀÌ·¯½º
  • acute hemorrhagic pancreatitis
    ±Þ¼º ÃéÀå¿°
    ´ã¼®Áõ, ÆØ´ëºÎ Æó¼â, ¸¸¼º ¾ËÄÚ¿Ã Áßµ¶, °ü³» °á¼®, Æó¼â¼º º´º¯, ¿µ¾ç°áÇÌ, ¹ÙÀÌ·¯½º, ¾à¹°, ÇãÇ÷, ¿Ü»ó µîÀÇ ¿øÀο¡ ÀÇÇØ ÀϾ´Ù. ÀÀ±Þ ÁúȯÀ̸ç ȯÀÚ´Â ´ëºÎºÐ ÆøÀ½ ¹× Æø½Ä ÈÄ¿¡ °©Àڱ⠹߻ýµÈ º¹ÅëÀ» ÁÖ¼Ò·Î º´¿ø¿¡ ¿À°Ô µÈ´Ù. ÃéÀå ºÎÀ§ÀÇ ±«»ç°¡ ½ÉÇÏ¸é »ç¸Á¿¡ À̸¦ ¼öµµ ÀÖ´Ù.
  • acute hepatitis
    ±Þ¼º °£¿°
    ÀÌ º´¸íÀº ¸·¿¬ÇÑ ¸íĪÀ¸·Î¼­, °£ÀÇ ±Þ¼º¡¤½ÇÁú¼º »óÇØÀÇ °ÅÀÇ ÀüºÎ¸¦ Æ÷°ýÇÏ´Â ³ÐÀº °³³äÀÌÁö¸¸, ½ÇÁ¦´Â ¹ÙÀÌ·¯½ºÀÇ °¨¿°À¸·Î »ý±â´Â °£¿°ÀÌ ´ëºÎºÐÀ̰í, °£µ¶¡¤È­Çоàǰ¡¤ÀǾàǰ µîÀ¸·Î »ý±â´Â Áßµ¶¼º °£¿°µµ ºñ±³Àû ¸¹´Ù. ¹ÙÀÌ·¯½º¼º °£¿°Àº À¯Ç༺ °£¿°
  • acute herpetic gingivostomatitis
    ±Þ¼º Æ÷Áø¼º Ä¡Àº±¸³»¿°
    ´Ü¼ø Æ÷Áø ¹ÙÀÌ·¯½º¿¡ ÀÇÇÑ ÀÕ¸ö°ú ÀÔ¼ú¿¡ ¹ß»ýÇÏ´Â ±Þ¼º ¿°Áõ.
  • acute HIV infection syndrome
    ±Þ¼º ÀÎü ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º Áúȯ °¨¿° ÁõÈıº
  • acute hydrocephaly
    ±Þ¼º ¼öµÎÁõ
  • acute hypoglycemia
    ±Þ¼º ÀúÇ÷´çÁõ
  • acute hypoxic encephalopathy
    ±Þ¼º Àú»ê¼Ò¼º ³úº´Áõ
  • acute idiopathic thrombocytopenic purpura
    ±Þ¼º Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹Ý º´
  • acute illness
    ±Þ¼º Áúº´, ±Þ¼º Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
acute contagious conjunctivitis An obsolete term for an acute conjunctivitis marked by intense hyperaemia and profuse mucopurulent discharge.
Synonym: acute epidemic conjunctivitis, pinkeye.
(05 Mar 2000)
acute crescentic glomerulonephritis <nephrology> A relatively uncommon (affecting 1 out of 10,000 people) form of acute glomerulonephritis that results in damage within the glomerulus of the kidney. There is rapid loss of kidney function with the formation of crescents on microscopic analysis (kidney biopsy). This disorder may result in acute glomerulonephritis or nephrotic syndrome, but ultimately results in renal failure and end-stage renal disease.
Symptoms include smoky coloured urine (pyuria), decreased urine output, swelling and hypertension. Any conditions which can cause a vasculitis increase the risk of this disorder. Some examples include lupus, Goodpasture's syndrome, Henoch-Schonlein purpura, IgA nephropathy, membranoproliferative glomerulonephritis, anti-glomerular basement membrane antibody disease, history for malignant tumours and exposure to hydrocarbon solvents.
(27 Sep 1997)
acute cutaneous leishmaniasis A form of cutaneous leishmaniasis characterised by rural distribution of human cases near infected rodents, particularly communal ground squirrels; characterised by acute rapidly developing dermal lesions that become severely inflamed, with moist necrotizing sores or ulcers that heal in two to eight months after a two to four month incubation period; among nonimmune immigrants, multiple lesions may develop, which heal more slowly and leave disabling or disfiguring scars. A strong delayed hypersensitivity and involvement of immune complexes play a role in necrosis, which is part of the healing process and of the strong specific immunity that follows.
Synonym: acute cutaneous leishmaniasis, rural cutaneous leishmaniasis, wet cutaneous leishmaniasis.
(05 Mar 2000)
acute decubitus ulcer A severe form of bedsore, of neutrophic origin, occurring in hemiplegia or paraplegia.
(05 Mar 2000)
acute delirium Delirium of recent, rapid onset.
(05 Mar 2000)
acute demyelinating polyneuropathy <neurology> A neurologic condition.
Synonym: Guillain-Barre syndrome.
Origin: Gr. Pathos = disease
(27 Sep 1997)
acute disease Disease having a short and relatively severe course.
(12 Dec 1998)
acute disseminated encephalomyelitis <radiology> Immune-mediated encephalitis (IME), ADE, allergic treatmentn to prior infection, begins 1-2 weeks after event, occus after viral infection or vaccination, affects corpus callosum and white matter (above and below tent), self-limited; steroids may help See also: white-matter disease, demyelinating disease
(12 Dec 1998)
acute disseminated myositis The occurrence of multiple foci of acute inflammation in the muscular tissue and overlying skin in various parts of the body, accompanied by fever and other signs of systemic infection.
See: dermatomyositis.
Synonym: acute disseminated myositis, pseudotrichinosis, pseudotrichiniasis.
(05 Mar 2000)
acute epidemic conjunctivitis An obsolete term for an acute conjunctivitis marked by intense hyperaemia and profuse mucopurulent discharge.
Synonym: acute epidemic conjunctivitis, pinkeye.
(05 Mar 2000)
acute epidemic leukoencephalitis A disease characterised by acute onset of fever, followed by convulsions, delirium, and coma, and associated with perivascular demyelination and haemorrhagic foci in the central nervous system.
Synonym: acute primary haemorrhagic meningoencephalitis, Strumpell's disease.
(05 Mar 2000)
acute extrinsic allergic alveolitis <radiology> No chest X-ray findings in 30-95%, diffuse acinar consolidative pattern (oedema and exudative filling of alveoli), basilar distribution, lymph node enlargement (unusual, more common with recurrence) see: extrinsic allergic alveolitis
(12 Dec 1998)
acute febrile illness An illness of sudden onset that manifests with fever.
(27 Sep 1997)
acute febrile neutrophilic dermatosis A rare dermatosis, predominant in women, of rapid onset and characterised by plaque-like lesions, usually multiple, on the face, neck, and upper extremities, accompanied by conjunctivitis, mucosal lesions, fever, malaise, arthralgia, and peripheral blood neutrophilia in many cases; biopsy reveals polymorphonuclear infiltrate of the dermis; rapid remission occurs with systemic steroid therapy.
Synonym: Sweet's disease.
(05 Mar 2000)
acute fibrinous pericarditis The usual lesion of acute pericarditis in which inflammation produces large quantities of fibrin.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á